Posts by tag

Local Pharma

88 posts

Formation of PharmEx Pakistan – Too Late, Too Little? – Asrar Qureshi’s Blog Post #1123

The Ministry of Commerce in Pakistan is launching PharmEx Pakistan to boost pharmaceutical exports, aiming to increase annual exports from $700 million to $3 billion. This public-private initiative, modeled after India’s Pharmexcil, seeks to enhance regulatory compliance and global visibility for Pakistani pharmaceuticals, while facing challenges in international competitiveness.
Share
View Post
  • 4 min

Pharmaceutical Marketing – Stuck in the Past – Asrar Qureshi’s Blog Post #1103

The blog post discusses the stagnation of pharmaceutical marketing due to reliance on outdated strategies, regulatory constraints, and risk aversion. It emphasizes the need for innovation through data-driven personalization, omnichannel engagement, and agile methodologies. A cultural shift toward collaboration and customer-centric approaches is essential for modernization and relevance in a changing landscape.
Share
View Post
  • 5 min

Influence of Gen AI on Pharmaceutical Marketing – Now and in Five Years – Asrar Qureshi’s Blog Post #1088

Asrar Qureshi’s blog discusses the transformative impact of Artificial Intelligence (AI) on pharmaceutical marketing, emphasizing its evolution towards more data-driven, personalized strategies. It highlights current capabilities, like AI in predictive analytics and content creation, while forecasting increased AI integration over the next five years, offering significant advantages to adaptable companies.
Share
View Post
  • 5 min

Disruption of Careers in Pharma Industry – Asrar Qureshi’s Blog Post #1018

Asrar Qureshi’s Blog Post discusses the evolution of career paths in Pakistan’s pharmaceutical industry over the past 40 years. It highlights the shift from MNC-led promotions to local companies hiring laterally, leading to unqualified promotions and ethical challenges. The post emphasizes the industry’s declining appeal as stress and burnout increase among employees despite higher perks and salaries.
Share